Coming from a family with a history of diabetes, I know how many needle pricks must be endured daily in order to avoid health complications. The BIORASIS Glucowizzard can be the answer diabetics have been waiting for.
Set to be released by 2017, the BIORASIS Glucowizzard is an implantable glucose sensor that will eliminate the need for finger-prick monitors, although will not replace insulin shots entirely. Read more about this amazing innovation.
What Makes This Trend Stand Out
- Implantable Medical Devices
- The trend towards implantable medical devices such as the BIORASIS Glucowizzard creates opportunities for innovative products and services that improve health monitoring and management.
- Continuous Glucose Monitoring
- Continuous glucose monitoring is a growing trend that presents opportunities for development of new sensing technology and analysis tools.
- AI-powered Glucose Management
- The use of artificial intelligence in glucose management presents an opportunity to revolutionize diabetes care by providing personalized, data-driven treatment plans.
Sectors Adopting This
- Medical Devices
- The medical device industry can capitalize on the growing trend of implantable glucose sensors by developing new products and services that improve health monitoring and management.
- Pharmaceuticals
- The pharmaceutical industry can leverage the trend towards continuous glucose monitoring by developing new treatments that improve diabetes management and reduce the need for insulin injections.
- AI and Machine Learning
- The trend towards AI-powered glucose management presents opportunities for the development of new machine learning algorithms and predictive analytics tools in healthcare.
